Neurobiology of cancer: Definition, historical overview, and clinical implications.

adrenergic signaling epinephrine hypothalamic-pituitary-adrenocortical axis innervation neurobiology of cancer norepinephrine propranolol psychoneuroimmunology stress sympathoadrenal system β-blockers

Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
02 2022
Historique:
revised: 15 11 2021
received: 18 07 2021
accepted: 17 11 2021
pubmed: 26 12 2021
medline: 19 4 2022
entrez: 25 12 2021
Statut: ppublish

Résumé

Studies published in the last two decades have clearly demonstrated that the nervous system plays a significant role in carcinogenesis, the progression of cancer, and the development of metastases. These studies, combining oncological and neuroscientific approaches, created the basis for the emergence of a new field in oncology research, the so-called "neurobiology of cancer." The concept of the neurobiology of cancer is based on several facts: (a) psychosocial factors influence the incidence and progression of cancer diseases; (b) the nervous system affects DNA mutations and oncogene-related signaling; (c) the nervous system modulates tumor-related immune responses; (d) tumor tissues are innervated; (e) neurotransmitters released from nerves innervating tumor tissues affect tumor growth and metastasis; (f) alterations or modulation of nervous system activity affects the incidence and progression of cancers; (g) tumor tissue affects the nervous system. The aim of this review is to characterize the pillars that create the basis of cancer neurobiology, to describe recent research advances of the nervous system's role in cancer diseases, and to depict potential clinical implications for oncology.

Identifiants

pubmed: 34953048
doi: 10.1002/cam4.4488
pmc: PMC8855902
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

903-921

Informations de copyright

© 2021 The Author. Cancer Medicine published by John Wiley & Sons Ltd.

Références

J Immunol. 1999 Sep 1;163(5):2492-9
pubmed: 10452985
Science. 2013 Jul 12;341(6142):1236361
pubmed: 23846904
Eur J Pharmacol. 2000 Sep 29;405(1-3):167-76
pubmed: 11033324
Cell Metab. 2018 Jul 03;28(1):118-129.e5
pubmed: 29805100
Br J Cancer. 2015 Apr 28;112(9):1461-70
pubmed: 25880007
Nat Rev Cancer. 2020 Mar;20(3):143-157
pubmed: 31974491
Prog Exp Tumor Res. 1970;13:1-27
pubmed: 4921480
Cancer Med. 2019 Jan;8(1):363-373
pubmed: 30600642
Cancer Res. 2018 Jun 15;78(12):3233-3242
pubmed: 29661830
Nature. 2019 May;569(7758):672-678
pubmed: 31092925
Brain Behav Immun. 2009 Feb;23(2):267-75
pubmed: 18996182
Br J Cancer. 2008 Oct 21;99(8):1269-75
pubmed: 18854825
Int J Mol Sci. 2021 Jun 06;22(11):
pubmed: 34204103
Brain Behav Immun. 2007 Aug;21(6):736-45
pubmed: 17467231
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Recept Signal Transduct. 1996;6(3-4):165-78
pubmed: 9259051
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
Anticancer Res. 2004 Mar-Apr;24(2B):1003-9
pubmed: 15161056
J Invest Dermatol. 1956 Nov;27(5):273-9
pubmed: 13385536
Clin Cancer Res. 2008 Dec 1;14(23):7593-603
pubmed: 19047084
Trends Cancer. 2017 Feb;3(2):89-112
pubmed: 28718448
Breast Cancer Res Treat. 2006 Oct;99(3):351-64
pubmed: 16583263
Cell Cycle. 2013 Jan 15;12(2):219-24
pubmed: 23287463
Br Med J (Clin Res Ed). 1984 May 5;288(6427):1335-8
pubmed: 6424847
Prog Exp Tumor Res. 2007;39:91-98
pubmed: 17314503
N Engl J Med. 2001 Dec 13;345(24):1719-26
pubmed: 11742045
Regul Pept. 2008 Nov 29;151(1-3):35-42
pubmed: 18499282
J Biol Chem. 1990 Aug 15;265(23):13809-17
pubmed: 1696258
Cancer. 2020 Sep 1;126(17):3991-4001
pubmed: 32533792
Front Immunol. 2018 Feb 06;9:164
pubmed: 29479349
Immunol Res. 2015 Dec;63(1-3):38-57
pubmed: 26512000
J Psychosom Res. 2004 Aug;57(2):123-31; discussion 133-5
pubmed: 15465065
PM R. 2011 Jul;3(7):633-6
pubmed: 21777862
Trends Cancer. 2017 Dec;3(12):812-815
pubmed: 29198437
Minerva Urol Nephrol. 2021 Jun;73(3):283-291
pubmed: 33439578
Cancer Prev Res (Phila). 2020 Feb;13(2):137-144
pubmed: 31619443
Immunol Today. 1995 Jul;16(7):318-22
pubmed: 7576063
Sci Rep. 2020 Jun 26;10(1):10465
pubmed: 32591592
Breast Cancer Res Treat. 2011 Jan;125(2):351-62
pubmed: 20237834
Int J Cancer. 2020 Dec 15;147(12):3281-3291
pubmed: 32510582
Palliat Med. 2004 Jan;18(1):25-31
pubmed: 14982204
Lancet. 1989 Oct 14;2(8668):888-91
pubmed: 2571815
BMJ. 1998 Feb 14;316(7130):518-9
pubmed: 9501714
Psychooncology. 2007 Apr;16(4):277-86
pubmed: 17385190
Int J Mol Sci. 2020 Mar 24;21(6):
pubmed: 32213975
Sci Rep. 2021 Apr 1;11(1):7390
pubmed: 33795769
Trends Neurosci. 2019 Aug;42(8):537-551
pubmed: 31213389
Nat Commun. 2013;4:1403
pubmed: 23360994
Med Hypotheses. 2020 Jan;134:109437
pubmed: 31655360
J Cancer Res Clin Oncol. 1990;116(3):303-6
pubmed: 2164516
Brain Behav Immun. 2012 Nov;26(8):1224-5
pubmed: 22890132
J Therm Biol. 2020 Apr;89:102538
pubmed: 32364983
Trends Cancer. 2020 Nov;6(11):951-959
pubmed: 32654993
Ann Palliat Med. 2016 Apr;5(2):93-106
pubmed: 27121737
J Neuroimmune Pharmacol. 2020 Mar;15(1):82-92
pubmed: 30762159
J BUON. 2016 May-Jun;21(3):756-9
pubmed: 27569105
J Neuroimmunol. 2020 Jul 3;346:577311
pubmed: 32652365
Int J Cancer. 1998 Jul 29;77(3):467-9
pubmed: 9663612
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3078-83
pubmed: 26929329
Radiat Res. 2019 Jun;191(6):585-589
pubmed: 31021732
Cancer Res. 1949 Dec;9(12):707-11, illust
pubmed: 15395904
PLoS One. 2018 Dec 10;13(12):e0208593
pubmed: 30532184
JAMA Oncol. 2019 Jan 1;5(1):106-107
pubmed: 30489606
Cancer Res. 2001 Apr 1;61(7):2866-9
pubmed: 11306460
Nature. 2018 Oct;562(7725):20-21
pubmed: 30279600
Immunity. 2017 Jun 20;46(6):927-942
pubmed: 28636960
Brain Behav Immun. 2018 Oct;73:364-374
pubmed: 29852290
Gynecol Oncol. 2015 Jan;136(1):99-103
pubmed: 25451694
Pancreas. 2004 Aug;29(2):e51-8
pubmed: 15257115
Clin Cancer Res. 2003 Oct 1;9(12):4514-21
pubmed: 14555525
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Nat Commun. 2020 Apr 14;11(1):1821
pubmed: 32286326
Sci Rep. 2020 Sep 9;10(1):14824
pubmed: 32908180
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7013-8
pubmed: 22509031
Ann Oncol. 2012 Sep;23 Suppl 8:viii6-9
pubmed: 22918931
J Neuroimmunol. 2013 Jul 15;260(1-2):37-46
pubmed: 23673146
Eur J Neurosci. 2005 May;21(10):2752-66
pubmed: 15926923
Cancer Discov. 2019 Jun;9(6):702-710
pubmed: 30944117
Clin Cancer Res. 2021 Jan 1;27(1):87-95
pubmed: 33127652
Arch Gen Psychiatry. 1993 Sep;50(9):681-9
pubmed: 8357293
Sci Rep. 2020 Jan 30;10(1):1539
pubmed: 32001748
J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):230-1
pubmed: 9722327
Nature. 2020 Feb;578(7795):449-454
pubmed: 32051587
Am J Gastroenterol. 2007 Jun;102(6):1185-91
pubmed: 17355418
Cancer. 2011 Nov 1;117(21):4834-45
pubmed: 21480205
Cancer Cell. 2017 Mar 13;31(3):342-354
pubmed: 28292437
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9105-10
pubmed: 18562281
Virchows Arch. 2002 Mar;440(3):291-7
pubmed: 11889600
Int J Cancer. 1992 Jan 21;50(2):298-301
pubmed: 1730523
Neuroendocrinology. 1986;42(5):407-15
pubmed: 3703160
Eur J Cancer Prev. 1991 Oct;1(1):35-7
pubmed: 1842681
J Clin Invest. 2019 Dec 2;129(12):5537-5552
pubmed: 31566578
Ann N Y Acad Sci. 1998 May 1;840:301-16
pubmed: 9629258
Curr Opin Clin Nutr Metab Care. 2017 Sep;20(5):396-401
pubmed: 28708669
Cancer. 2007 Sep 1;110(5):1130-8
pubmed: 17647221
Anticancer Drugs. 2008 Aug;19(7):655-71
pubmed: 18594207
Immunol Res. 2014 May;58(2-3):193-210
pubmed: 24798553
Nature. 2011 Aug 21;477(7364):349-53
pubmed: 21857681
Int J Colorectal Dis. 1988 Aug;3(3):144-8
pubmed: 3183474
Brain Behav Immun. 2011 Mar;25(3):555-64
pubmed: 21182930
Clio Med. 1975 Sep;10(3):227-38
pubmed: 50913
Br Med J. 1903 Apr 18;1(2207):904-8
pubmed: 20760845
Eur J Surg Oncol. 2007 Aug;33(6):706-12
pubmed: 17207958
Philos Trans R Soc Lond B Biol Sci. 1947;232(590):385-441
pubmed: 20295317
Proc Natl Acad Sci U S A. 1915 Jul;1(7):435-7
pubmed: 16576038
Can Med Assoc J. 1928 Feb;18(2):135-9
pubmed: 20316697
Brain Behav Immun. 2008 Mar;22(3):318-23
pubmed: 17981009
Cancer Med. 2022 Feb;11(4):903-921
pubmed: 34953048
Neuroendocrinology. 1980;30(2):88-93
pubmed: 6986579
Eur Urol. 2009 Jul;56(1):142-8
pubmed: 18280636
Blood Adv. 2020 Feb 11;4(3):467-476
pubmed: 32027744
Prostate Cancer Prostatic Dis. 2006;9(2):115-20
pubmed: 16534510
JAMA Oncol. 2018 Feb 8;4(2):e172908
pubmed: 28973254
Med Hypotheses. 2002 Sep;59(3):302-11
pubmed: 12208157
Nat Neurosci. 2019 Aug;22(8):1289-1305
pubmed: 31285612
Cancer Res. 2006 Nov 1;66(21):10357-64
pubmed: 17079456
Cancer Cell. 2018 Jan 8;33(1):75-90.e7
pubmed: 29249692
Eur J Neurosci. 2020 Jun;51(12):2376-2393
pubmed: 31883212
Adv Exp Med Biol. 2017;1036:173-189
pubmed: 29275472
Psychoneuroendocrinology. 2007 Jun;32(5):470-9
pubmed: 17459596
Int J Mol Sci. 2020 Oct 26;21(21):
pubmed: 33114769
Nat Rev Cancer. 2015 Sep;15(9):563-72
pubmed: 26299593
Virchows Arch. 2001 Mar;438(3):228-31
pubmed: 11315618
Breast Cancer Res Treat. 1989 Jul;13(3):251-63
pubmed: 2569332
Clin Cancer Res. 2017 Aug 15;23(16):4651-4661
pubmed: 28490464
Exp Cell Res. 1988 Nov;179(1):194-203
pubmed: 2844568
Psychosom Med. 1975 Jul-Aug;37(4):333-40
pubmed: 1162023
Sci Transl Med. 2014 Aug 20;6(250):250ra115
pubmed: 25143365
Clin Transl Oncol. 2021 Apr;23(4):669-681
pubmed: 32770391
J Exp Med. 1897 Jan 1;2(1):1-12
pubmed: 19866822
Prostate. 2021 Jan;81(1):58-71
pubmed: 33022812
Nat Rev Cancer. 2021 Dec;21(12):767-785
pubmed: 34508247
Proc Staff Meet Mayo Clin. 1950 Aug 16;25(17):476-8
pubmed: 15440923

Auteurs

Boris Mravec (B)

Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH